李偉豪+謝澤榮+黃桂磐

【摘要】 目的：觀察虎奶菇提純物聯(lián)合布地奈德對(duì)小兒支氣管哮喘發(fā)作期呼吸力學(xué)及細(xì)胞免疫功能的影響，探討虎奶菇提純物聯(lián)合布地奈德在小兒支氣管哮喘發(fā)作期中的臨床療效。方法：選擇2014年2月-2016年8月本院兒科門(mén)診部支氣管哮喘發(fā)作期的患兒180例，按照隨機(jī)數(shù)字表法分為A觀察組、B觀察組和對(duì)照組，各60例，對(duì)照組給予對(duì)癥治療，A觀察組在對(duì)照組治療的基礎(chǔ)上再給予布地奈德治療，B觀察組在對(duì)照組治療的基礎(chǔ)上再給予虎奶菇提純物聯(lián)合布地奈德治療，比較分析三組療效、呼吸力學(xué)參數(shù)及細(xì)胞免疫功能的改變。結(jié)果：治療后，A觀察組、B觀察組和對(duì)照組總有效率分別為81.7%、96.7%和71.7%，B觀察組的總有效率優(yōu)于A觀察組和對(duì)照組，A觀察組的總有效率優(yōu)于對(duì)照組，差異均有統(tǒng)計(jì)學(xué)意義（P<0.05）；B觀察組的動(dòng)脈血氧分壓（PaO2）、動(dòng)脈血二氧化碳分壓（PaCO2）、動(dòng)脈血氧飽和度（SaO2）、動(dòng)脈血?dú)庵笜?biāo)計(jì)算肺血分流率（Qs/Qt）、氣道峰壓（PIP）、氣道阻力（Raw）、呼吸做功（WOB）和動(dòng)態(tài)肺順應(yīng)性（Cdyn）改變均優(yōu)于A觀察組和對(duì)照組，差異均有統(tǒng)計(jì)學(xué)意義（P<0.05）；A觀察組PaO2、PaCO2、SaO2、Qs/Qt、PIP、Raw、WOB和Cdyn改變均優(yōu)于對(duì)照組，差異均有統(tǒng)計(jì)學(xué)意義（P<0.05）；B觀察組的外周血T淋巴細(xì)胞亞群CD4+、CD3+和CD4+/CD8+的百分比數(shù)值較A觀察組和對(duì)照組均顯著降低，B觀察組的CD8+水平較A觀察組和對(duì)照組均顯著升高，差異均有統(tǒng)計(jì)學(xué)意義（P<0.05）；A觀察組的外周血T淋巴細(xì)胞亞群CD4+、CD3+和CD4+/CD8+的百分比數(shù)值較對(duì)照組均顯著降低，A觀察組的CD8+水平較對(duì)照組顯著升高，差異均有統(tǒng)計(jì)學(xué)意義（P<0.05）。結(jié)論：虎奶菇提純物聯(lián)合布地奈德治療兒童支氣管哮喘發(fā)作期，能明顯改善細(xì)胞免疫功能，提高肺的順應(yīng)性和肺氧合率，改善體內(nèi)缺氧狀態(tài)，可以顯著地緩解哮喘癥狀，值得臨床推廣。

【關(guān)鍵詞】 兒童； 哮喘； 虎奶菇； 布地奈德； 呼吸力學(xué)； 免疫功能

Effects of Pleurotus Tuber Extract and Budesonide on Respiratory Mechanics and Cellular Immune Function in Children with Bronchial Asthma/LI Wei-hao，XIE Ze-rong，HUANG Gui-pan.//Medical Innovation of China，2017，14（17）：005-009

【Abstract】 Objective：To observe the effect of Pleurotus Tuber Extract combined with Budesonide on respiratory mechanics and cellular immune function in children with bronchial asthma，and to explore the clinical effect of Pleurotus Tuber Extract combined with Budesonide in children bronchial asthma.Method：180 cases of children with bronchial asthma who were selected from February 2014 to August 2016 in our hospital pediatric outpatient department were randomly divided into A observation group，B observation group and the control group，60 cases in each group，the control group was given symptomatic treatment，A observation group on the basis of in the control group was given Budesonide，B observation group on the basis of the control group was given Pleurotus Tuber Extract combined with Budesonide.The efficacy，respiratory mechanics parameters and changes in cellular immune function of three groups were compared.Result：After treatment，the total effective rates of A observation group，B observation group and the control group were 81.7%，96.7% and 71.7%，and B observation group was better compared with A observation group and the control group，A observation group was better than that of the control group，the differences were statistically significant（P<0.05）.The changes of arterial oxygen（PaO2），arterial carbon dioxide tension（PaCO2），arterial oxygen saturation（SaO2），arterial blood gas index calculation pulmonary shunt fraction（Qs/Qt），peak airway pressure（PIP），airway resistance（Raw），respiratory work（WOB） and dynamic lung compliance（Cdyn） in B observation group were better than those of A observation group and the control group，the differences were statistically significant（P<0.05）.The changes of PaO2，PaCO2，SaO2，Qs/Qt，PIP，Raw，WOB and Cdyn in the observation group that were better than those in the control group，the differences were statistically significant（P<0.05）.The percentage of CD4+，CD3+ and CD4+/CD8+ in the peripheral blood T lymphocyte subsets of B observation group was significantly lower than those of A observation group and the control group，the level of CD8+ in B observation group was significantly higher than that in A observation group and the control group（P<0.05）.The percentage of CD4+，CD3+ and CD4+/CD8+ in the peripheral blood T lymphocyte subsets of A observation group were significantly lower than those of the control group，and the level of CD8+ in A observation group was significantly higher than that in the control group （P<0.05）.Conclusion：Pleurotus Tuber Extract combined with Budesonide in the treatment of children with bronchial asthma attack，can significantly improve the childrens cellular immune function，improve lung compliance and lung oxygenation rate，improve the body hypoxia，can significantly alleviate the suffering Childrens asthma symptoms，it is worthy of clinical promotion.

【摘要】 目的：觀察虎奶菇提純物聯(lián)合布地奈德對(duì)小兒支氣管哮喘發(fā)作期呼吸力學(xué)及細(xì)胞免疫功能的影響，探討虎奶菇提純物聯(lián)合布地奈德在小兒支氣管哮喘發(fā)作期中的臨床療效。方法：選擇2014年2月-2016年8月本院兒科門(mén)診部支氣管哮喘發(fā)作期的患兒180例，按照隨機(jī)數(shù)字表法分為A觀察組、B觀察組和對(duì)照組，各60例，對(duì)照組給予對(duì)癥治療，A觀察組在對(duì)照組治療的基礎(chǔ)上再給予布地奈德治療，B觀察組在對(duì)照組治療的基礎(chǔ)上再給予虎奶菇提純物聯(lián)合布地奈德治療，比較分析三組療效、呼吸力學(xué)參數(shù)及細(xì)胞免疫功能的改變。結(jié)果：治療后，A觀察組、B觀察組和對(duì)照組總有效率分別為81.7%、96.7%和71.7%，B觀察組的總有效率優(yōu)于A觀察組和對(duì)照組，A觀察組的總有效率優(yōu)于對(duì)照組，差異均有統(tǒng)計(jì)學(xué)意義（P<0.05）；B觀察組的動(dòng)脈血氧分壓（PaO2）、動(dòng)脈血二氧化碳分壓（PaCO2）、動(dòng)脈血氧飽和度（SaO2）、動(dòng)脈血?dú)庵笜?biāo)計(jì)算肺血分流率（Qs/Qt）、氣道峰壓（PIP）、氣道阻力（Raw）、呼吸做功（WOB）和動(dòng)態(tài)肺順應(yīng)性（Cdyn）改變均優(yōu)于A觀察組和對(duì)照組，差異均有統(tǒng)計(jì)學(xué)意義（P<0.05）；A觀察組PaO2、PaCO2、SaO2、Qs/Qt、PIP、Raw、WOB和Cdyn改變均優(yōu)于對(duì)照組，差異均有統(tǒng)計(jì)學(xué)意義（P<0.05）；B觀察組的外周血T淋巴細(xì)胞亞群CD4+、CD3+和CD4+/CD8+的百分比數(shù)值較A觀察組和對(duì)照組均顯著降低，B觀察組的CD8+水平較A觀察組和對(duì)照組均顯著升高，差異均有統(tǒng)計(jì)學(xué)意義（P<0.05）；A觀察組的外周血T淋巴細(xì)胞亞群CD4+、CD3+和CD4+/CD8+的百分比數(shù)值較對(duì)照組均顯著降低，A觀察組的CD8+水平較對(duì)照組顯著升高，差異均有統(tǒng)計(jì)學(xué)意義（P<0.05）。結(jié)論：虎奶菇提純物聯(lián)合布地奈德治療兒童支氣管哮喘發(fā)作期，能明顯改善細(xì)胞免疫功能，提高肺的順應(yīng)性和肺氧合率，改善體內(nèi)缺氧狀態(tài)，可以顯著地緩解哮喘癥狀，值得臨床推廣。

【關(guān)鍵詞】 兒童； 哮喘； 虎奶菇； 布地奈德； 呼吸力學(xué)； 免疫功能

Effects of Pleurotus Tuber Extract and Budesonide on Respiratory Mechanics and Cellular Immune Function in Children with Bronchial Asthma/LI Wei-hao，XIE Ze-rong，HUANG Gui-pan.//Medical Innovation of China，2017，14（17）：005-009

【Abstract】 Objective：To observe the effect of Pleurotus Tuber Extract combined with Budesonide on respiratory mechanics and cellular immune function in children with bronchial asthma，and to explore the clinical effect of Pleurotus Tuber Extract combined with Budesonide in children bronchial asthma.Method：180 cases of children with bronchial asthma who were selected from February 2014 to August 2016 in our hospital pediatric outpatient department were randomly divided into A observation group，B observation group and the control group，60 cases in each group，the control group was given symptomatic treatment，A observation group on the basis of in the control group was given Budesonide，B observation group on the basis of the control group was given Pleurotus Tuber Extract combined with Budesonide.The efficacy，respiratory mechanics parameters and changes in cellular immune function of three groups were compared.Result：After treatment，the total effective rates of A observation group，B observation group and the control group were 81.7%，96.7% and 71.7%，and B observation group was better compared with A observation group and the control group，A observation group was better than that of the control group，the differences were statistically significant（P<0.05）.The changes of arterial oxygen（PaO2），arterial carbon dioxide tension（PaCO2），arterial oxygen saturation（SaO2），arterial blood gas index calculation pulmonary shunt fraction（Qs/Qt），peak airway pressure（PIP），airway resistance（Raw），respiratory work（WOB） and dynamic lung compliance（Cdyn） in B observation group were better than those of A observation group and the control group，the differences were statistically significant（P<0.05）.The changes of PaO2，PaCO2，SaO2，Qs/Qt，PIP，Raw，WOB and Cdyn in the observation group that were better than those in the control group，the differences were statistically significant（P<0.05）.The percentage of CD4+，CD3+ and CD4+/CD8+ in the peripheral blood T lymphocyte subsets of B observation group was significantly lower than those of A observation group and the control group，the level of CD8+ in B observation group was significantly higher than that in A observation group and the control group（P<0.05）.The percentage of CD4+，CD3+ and CD4+/CD8+ in the peripheral blood T lymphocyte subsets of A observation group were significantly lower than those of the control group，and the level of CD8+ in A observation group was significantly higher than that in the control group （P<0.05）.Conclusion：Pleurotus Tuber Extract combined with Budesonide in the treatment of children with bronchial asthma attack，can significantly improve the childrens cellular immune function，improve lung compliance and lung oxygenation rate，improve the body hypoxia，can significantly alleviate the suffering Childrens asthma symptoms，it is worthy of clinical promotion.

【摘要】 目的：觀察虎奶菇提純物聯(lián)合布地奈德對(duì)小兒支氣管哮喘發(fā)作期呼吸力學(xué)及細(xì)胞免疫功能的影響，探討虎奶菇提純物聯(lián)合布地奈德在小兒支氣管哮喘發(fā)作期中的臨床療效。方法：選擇2014年2月-2016年8月本院兒科門(mén)診部支氣管哮喘發(fā)作期的患兒180例，按照隨機(jī)數(shù)字表法分為A觀察組、B觀察組和對(duì)照組，各60例，對(duì)照組給予對(duì)癥治療，A觀察組在對(duì)照組治療的基礎(chǔ)上再給予布地奈德治療，B觀察組在對(duì)照組治療的基礎(chǔ)上再給予虎奶菇提純物聯(lián)合布地奈德治療，比較分析三組療效、呼吸力學(xué)參數(shù)及細(xì)胞免疫功能的改變。結(jié)果：治療后，A觀察組、B觀察組和對(duì)照組總有效率分別為81.7%、96.7%和71.7%，B觀察組的總有效率優(yōu)于A觀察組和對(duì)照組，A觀察組的總有效率優(yōu)于對(duì)照組，差異均有統(tǒng)計(jì)學(xué)意義（P<0.05）；B觀察組的動(dòng)脈血氧分壓（PaO2）、動(dòng)脈血二氧化碳分壓（PaCO2）、動(dòng)脈血氧飽和度（SaO2）、動(dòng)脈血?dú)庵笜?biāo)計(jì)算肺血分流率（Qs/Qt）、氣道峰壓（PIP）、氣道阻力（Raw）、呼吸做功（WOB）和動(dòng)態(tài)肺順應(yīng)性（Cdyn）改變均優(yōu)于A觀察組和對(duì)照組，差異均有統(tǒng)計(jì)學(xué)意義（P<0.05）；A觀察組PaO2、PaCO2、SaO2、Qs/Qt、PIP、Raw、WOB和Cdyn改變均優(yōu)于對(duì)照組，差異均有統(tǒng)計(jì)學(xué)意義（P<0.05）；B觀察組的外周血T淋巴細(xì)胞亞群CD4+、CD3+和CD4+/CD8+的百分比數(shù)值較A觀察組和對(duì)照組均顯著降低，B觀察組的CD8+水平較A觀察組和對(duì)照組均顯著升高，差異均有統(tǒng)計(jì)學(xué)意義（P<0.05）；A觀察組的外周血T淋巴細(xì)胞亞群CD4+、CD3+和CD4+/CD8+的百分比數(shù)值較對(duì)照組均顯著降低，A觀察組的CD8+水平較對(duì)照組顯著升高，差異均有統(tǒng)計(jì)學(xué)意義（P<0.05）。結(jié)論：虎奶菇提純物聯(lián)合布地奈德治療兒童支氣管哮喘發(fā)作期，能明顯改善細(xì)胞免疫功能，提高肺的順應(yīng)性和肺氧合率，改善體內(nèi)缺氧狀態(tài)，可以顯著地緩解哮喘癥狀，值得臨床推廣。

【關(guān)鍵詞】 兒童； 哮喘； 虎奶菇； 布地奈德； 呼吸力學(xué)； 免疫功能

Effects of Pleurotus Tuber Extract and Budesonide on Respiratory Mechanics and Cellular Immune Function in Children with Bronchial Asthma/LI Wei-hao，XIE Ze-rong，HUANG Gui-pan.//Medical Innovation of China，2017，14（17）：005-009

【Abstract】 Objective：To observe the effect of Pleurotus Tuber Extract combined with Budesonide on respiratory mechanics and cellular immune function in children with bronchial asthma，and to explore the clinical effect of Pleurotus Tuber Extract combined with Budesonide in children bronchial asthma.Method：180 cases of children with bronchial asthma who were selected from February 2014 to August 2016 in our hospital pediatric outpatient department were randomly divided into A observation group，B observation group and the control group，60 cases in each group，the control group was given symptomatic treatment，A observation group on the basis of in the control group was given Budesonide，B observation group on the basis of the control group was given Pleurotus Tuber Extract combined with Budesonide.The efficacy，respiratory mechanics parameters and changes in cellular immune function of three groups were compared.Result：After treatment，the total effective rates of A observation group，B observation group and the control group were 81.7%，96.7% and 71.7%，and B observation group was better compared with A observation group and the control group，A observation group was better than that of the control group，the differences were statistically significant（P<0.05）.The changes of arterial oxygen（PaO2），arterial carbon dioxide tension（PaCO2），arterial oxygen saturation（SaO2），arterial blood gas index calculation pulmonary shunt fraction（Qs/Qt），peak airway pressure（PIP），airway resistance（Raw），respiratory work（WOB） and dynamic lung compliance（Cdyn） in B observation group were better than those of A observation group and the control group，the differences were statistically significant（P<0.05）.The changes of PaO2，PaCO2，SaO2，Qs/Qt，PIP，Raw，WOB and Cdyn in the observation group that were better than those in the control group，the differences were statistically significant（P<0.05）.The percentage of CD4+，CD3+ and CD4+/CD8+ in the peripheral blood T lymphocyte subsets of B observation group was significantly lower than those of A observation group and the control group，the level of CD8+ in B observation group was significantly higher than that in A observation group and the control group（P<0.05）.The percentage of CD4+，CD3+ and CD4+/CD8+ in the peripheral blood T lymphocyte subsets of A observation group were significantly lower than those of the control group，and the level of CD8+ in A observation group was significantly higher than that in the control group （P<0.05）.Conclusion：Pleurotus Tuber Extract combined with Budesonide in the treatment of children with bronchial asthma attack，can significantly improve the childrens cellular immune function，improve lung compliance and lung oxygenation rate，improve the body hypoxia，can significantly alleviate the suffering Childrens asthma symptoms，it is worthy of clinical promotion.

綜上所述，使用虎奶菇提純物聯(lián)合布地奈德治療兒童支氣管哮喘發(fā)作期，可明顯改善細(xì)胞免疫功能，提高肺順應(yīng)性和肺氧合率，改善體內(nèi)缺氧狀態(tài)，可以顯著地緩解哮喘癥狀，并且虎奶菇提純物溶液味清香，患兒依從性極好，值得臨床推廣。

參考文獻(xiàn)

[1]謝炳林，李兆子，何永紅.布地奈德霧化吸入對(duì)小兒支氣管哮喘免疫功能影響的臨床研究[J].中國(guó)實(shí)用醫(yī)藥，2015，10（14）：191-193.

[2]中華醫(yī)學(xué)會(huì)呼吸病學(xué)分會(huì)，慢性阻塞性肺疾病學(xué)組.慢性阻塞性肺疾病診治指 南（2007年修訂版）[J].中華內(nèi)科雜志，2007，46（3）：254.

[3]白桂林，韋祁山.布地奈德與細(xì)辛腦聯(lián)合霧化吸入對(duì)小兒喘憋性肺炎的療效觀察[J].中國(guó)初級(jí)衛(wèi)生保健，2016，30（4）：76-77.

[4]嚴(yán)煒，劉丹，易海若.嬰幼兒支氣管哮喘與細(xì)胞免疫功能異常的研究[J].中國(guó)婦幼健康研究，2013，24（2）：248-250.

[5]許芳.孟魯司特鈉聯(lián)合布地奈德治療兒童咳嗽變異性哮喘的臨床療效和安全性評(píng)價(jià)[J].中國(guó)現(xiàn)代醫(yī)生，2014，52（7）：68-69，72.

[6]黃必勝，胡衡.虎奶多糖免疫功能試驗(yàn)研究[J].時(shí)珍國(guó)醫(yī)藥，2000，1（8）：685-686.

[7]中華醫(yī)學(xué)會(huì)兒科學(xué)分會(huì)呼吸學(xué)組，中華醫(yī)學(xué)會(huì)《中華兒科雜志》編輯委員.兒童支氣管哮喘防治常規(guī)（試行）[J].中華兒科雜志，2004，42（2）：100-106.

[8]李蘭英，王洪云，陳艷波，等.布地奈德混懸液霧化吸人與強(qiáng)的松口服治療成人支氣管哮喘急性發(fā)作的療效比較[J].實(shí)用醫(yī)學(xué)雜志，2011，27（14）：2629-2631.

[9]關(guān)楚翹，吳東亮.從龍溫膽湯聯(lián)合喘可治注射液治療小兒急性發(fā)作期支氣管哮喘療效及對(duì)免疫功能的影響[J].現(xiàn)代中西醫(yī)結(jié)合雜志，2016，25（20）：2218-2220.

[10]張鵬，張靜.堿提虎奶菇菌核多糖的分離純化及結(jié)構(gòu)分析[J].陜西師范大學(xué)學(xué)報(bào)（自然科學(xué)版），2103，41（4）：105-108.

[11]全國(guó)兒科哮喘協(xié)助組，中國(guó)疾病預(yù)防控制中心環(huán)境與健康相關(guān)產(chǎn)品安全所.第三次中國(guó)城市兒童哮喘流行病學(xué)調(diào)查[J].中華兒科雜志，2013，51（10）：729-35.

[12]馮麗燕，檀衛(wèi)平.東莞太平地區(qū)兒童支氣管哮喘急性發(fā)作期的病毒感染特征[J].新醫(yī)學(xué)，2015，46（3）：177-179.

[13] Zhu T，Zhang W，Wang D X，et al.Rosuvastatin attenuates mucus secretion in a murine model of chronic asthma by inhibiting the gamma-aminobutyric acid type A receptor[J].Chin Med J（Engl），2012，125（8）：1457-1464.

[14] Xiao M，Zhu T，Wng T，et al.Hydrogen-rich saline reduces airway remodeling viainactivation of NF-κB in a murine model of a sthma[J].Eur Rev Med Pharmacol Sci，2013，17（8）：1033-1043.

[15]張維，朱濤，王導(dǎo)新，等.瑞舒伐他汀抑制小鼠哮喘模型慢性氣道炎癥反應(yīng)的實(shí)驗(yàn)研究[J].西部醫(yī)學(xué)，2014，26（2）：150-153.

[16]趙慶祝，閏志剛，張姣珍.布地奈德聯(lián)合阿奇霉素治療小兒肺炎支原體感染28例臨床觀察[J].臨床合理用藥雜志，2015，8（14）：76-77.

[17]高瑾.吸入布地奈德在治療新生兒肺炎中的臨床療效[J].實(shí)用臨床醫(yī)藥雜志，2013，17（17）：108-109.

[18]吳錦忠，黃麗敏，張志強(qiáng).虎奶菇揮發(fā)油成分分析[J].福建中醫(yī)學(xué)院學(xué)報(bào)，2002，12（1）：34-36.

[19]李作卿.布地奈德聯(lián)合沙丁胺醇霧化吸入治療慢阻肺急性加重期臨床觀察[J].基層醫(yī)學(xué)論壇，2016，20（19）：2661-2662.

[20]李榮同，包水明，陳傳紅，等.菌核側(cè)耳畸形菇出現(xiàn)原因及防治[J].食用菌，2005，27（2）：52-53.

[21]曾小龍，胡高蒙.虎奶菇的化學(xué)成分與藥理作用研究[J].中國(guó)食用菌，2007，26（5）：3-7.

[22]劉阿娟，張靜，張化朋.虎奶菇菌核多糖SHNP的分離純化及形貌觀測(cè)[J].農(nóng)產(chǎn)品加工（學(xué)刊），2013，28（9）：66-69.

（收稿日期：2017-01-16） （本文編輯：程旭然）